{"title":"泛癌单细胞和空间转录组学暗示癌症相关成纤维细胞参与中性粒细胞免疫抑制表型转变和免疫治疗耐药性","authors":"Zhiyu Guo, Xujia Li, Lingli Huang, Yue Yan, Mengge Gao, Jinsheng Huang","doi":"10.1007/s10142-025-01706-x","DOIUrl":null,"url":null,"abstract":"<div><p>Neutrophils are the most abundant granulocyte population and have important functions such as defense against pathogens. However, they show significant Heterogeneity and play more complex roles in tumors. The theory of two-tiered differentiation of neutrophils is insufficient to summarize their phenotypic and functional Heterogeneity. Therefore, specific regulatory mechanisms remain to be explored and neutrophil-based therapeutic regimens remain challenging. Here, we generated a single-cell atlas of neutrophils from 462 patients with 21 cancer types, revealing their heterogeneity, with CXCR2 + VNN2 + Neu as the main functional subpopulation exerting immunosuppressive effects. Spatial transcriptomic analysis across pan-cancer tissues revealed an association between fibroblast activity and the phenotypic transition of CXCR2 + VNN2 + Neu, potentially enabling their acquisition of immunosuppressive functions via ligand-receptor interactions, cytokine signaling, and extracellular vesicle communication. These findings imply that tumor microenvironment components may contribute to the heterogeneous prognostic associations observed between neutrophils and clinical outcomes in pan-cancer patients. Subsequently, we constructed a gene regulatory network to demonstrate the specific regulatory mechanisms of CXCR2 + VNN2 + Neu and identified BACH1 and ATF2 as potential therapeutic targets. Combination therapy may enhance the efficacy of neutrophil-based therapeutic regimens. Analysis of pan-cancer immunotherapy cohorts revealed a significant correlation between CXCR2 + VNN2 + Neu phenotypic transition and immunotherapy resistance in patients. We finally constructed a deep learning model named Deepsurv to accurately stratify pan-cancer patients based on the CXCR2 + VNN2 + Neu Phenotypic Transition Gene Regulatory Network (CVN-GRN) and predict the prognosis of the patients, which achieved the desired results.</p></div>","PeriodicalId":574,"journal":{"name":"Functional & Integrative Genomics","volume":"25 1","pages":""},"PeriodicalIF":3.1000,"publicationDate":"2025-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Pan-cancer single-cell and spatial transcriptomics implicate cancer-associated fibroblasts in neutrophil immunosuppressive phenotypic transitions and immunotherapy resistance\",\"authors\":\"Zhiyu Guo, Xujia Li, Lingli Huang, Yue Yan, Mengge Gao, Jinsheng Huang\",\"doi\":\"10.1007/s10142-025-01706-x\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>Neutrophils are the most abundant granulocyte population and have important functions such as defense against pathogens. However, they show significant Heterogeneity and play more complex roles in tumors. The theory of two-tiered differentiation of neutrophils is insufficient to summarize their phenotypic and functional Heterogeneity. Therefore, specific regulatory mechanisms remain to be explored and neutrophil-based therapeutic regimens remain challenging. Here, we generated a single-cell atlas of neutrophils from 462 patients with 21 cancer types, revealing their heterogeneity, with CXCR2 + VNN2 + Neu as the main functional subpopulation exerting immunosuppressive effects. Spatial transcriptomic analysis across pan-cancer tissues revealed an association between fibroblast activity and the phenotypic transition of CXCR2 + VNN2 + Neu, potentially enabling their acquisition of immunosuppressive functions via ligand-receptor interactions, cytokine signaling, and extracellular vesicle communication. These findings imply that tumor microenvironment components may contribute to the heterogeneous prognostic associations observed between neutrophils and clinical outcomes in pan-cancer patients. Subsequently, we constructed a gene regulatory network to demonstrate the specific regulatory mechanisms of CXCR2 + VNN2 + Neu and identified BACH1 and ATF2 as potential therapeutic targets. Combination therapy may enhance the efficacy of neutrophil-based therapeutic regimens. Analysis of pan-cancer immunotherapy cohorts revealed a significant correlation between CXCR2 + VNN2 + Neu phenotypic transition and immunotherapy resistance in patients. We finally constructed a deep learning model named Deepsurv to accurately stratify pan-cancer patients based on the CXCR2 + VNN2 + Neu Phenotypic Transition Gene Regulatory Network (CVN-GRN) and predict the prognosis of the patients, which achieved the desired results.</p></div>\",\"PeriodicalId\":574,\"journal\":{\"name\":\"Functional & Integrative Genomics\",\"volume\":\"25 1\",\"pages\":\"\"},\"PeriodicalIF\":3.1000,\"publicationDate\":\"2025-10-10\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Functional & Integrative Genomics\",\"FirstCategoryId\":\"99\",\"ListUrlMain\":\"https://link.springer.com/article/10.1007/s10142-025-01706-x\",\"RegionNum\":4,\"RegionCategory\":\"生物学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"GENETICS & HEREDITY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Functional & Integrative Genomics","FirstCategoryId":"99","ListUrlMain":"https://link.springer.com/article/10.1007/s10142-025-01706-x","RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"GENETICS & HEREDITY","Score":null,"Total":0}
Pan-cancer single-cell and spatial transcriptomics implicate cancer-associated fibroblasts in neutrophil immunosuppressive phenotypic transitions and immunotherapy resistance
Neutrophils are the most abundant granulocyte population and have important functions such as defense against pathogens. However, they show significant Heterogeneity and play more complex roles in tumors. The theory of two-tiered differentiation of neutrophils is insufficient to summarize their phenotypic and functional Heterogeneity. Therefore, specific regulatory mechanisms remain to be explored and neutrophil-based therapeutic regimens remain challenging. Here, we generated a single-cell atlas of neutrophils from 462 patients with 21 cancer types, revealing their heterogeneity, with CXCR2 + VNN2 + Neu as the main functional subpopulation exerting immunosuppressive effects. Spatial transcriptomic analysis across pan-cancer tissues revealed an association between fibroblast activity and the phenotypic transition of CXCR2 + VNN2 + Neu, potentially enabling their acquisition of immunosuppressive functions via ligand-receptor interactions, cytokine signaling, and extracellular vesicle communication. These findings imply that tumor microenvironment components may contribute to the heterogeneous prognostic associations observed between neutrophils and clinical outcomes in pan-cancer patients. Subsequently, we constructed a gene regulatory network to demonstrate the specific regulatory mechanisms of CXCR2 + VNN2 + Neu and identified BACH1 and ATF2 as potential therapeutic targets. Combination therapy may enhance the efficacy of neutrophil-based therapeutic regimens. Analysis of pan-cancer immunotherapy cohorts revealed a significant correlation between CXCR2 + VNN2 + Neu phenotypic transition and immunotherapy resistance in patients. We finally constructed a deep learning model named Deepsurv to accurately stratify pan-cancer patients based on the CXCR2 + VNN2 + Neu Phenotypic Transition Gene Regulatory Network (CVN-GRN) and predict the prognosis of the patients, which achieved the desired results.
期刊介绍:
Functional & Integrative Genomics is devoted to large-scale studies of genomes and their functions, including systems analyses of biological processes. The journal will provide the research community an integrated platform where researchers can share, review and discuss their findings on important biological questions that will ultimately enable us to answer the fundamental question: How do genomes work?